Young Michael N, Singh Vikas, Sakhuja Rahul
Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, GRB8, Boston, MA, 02114, USA.
Curr Treat Options Cardiovasc Med. 2018 Jul 4;20(7):62. doi: 10.1007/s11936-018-0648-5.
With the advent of transcatheter aortic valve replacement (TAVR), appropriately selected intermediate-, high-, and extreme-risk patients with severe aortic stenosis (AS) are now offered a less invasive option compared to conventional surgery. In contemporary practice, TAVR is performed predominantly via a transfemoral arterial approach, whereby a transcatheter heart valve (THV) is delivered in a retrograde fashion through the iliofemoral arterial system and thoraco-abdominal aorta, into the native aortic valve annulus. While the majority of patients possess suitable anatomy for transfemoral arterial access, there is a subset of patients with extensive peripheral vascular disease that precludes this traditional approach to TAVR. Fortunately, innovation in the field of structural heart disease has led to the refinement of alternative access options for THV delivery. Selection of the most appropriate route of therapy mandates a careful consideration of multiple factors, including patient anatomy, technical feasibility, and equipment specifications. Furthermore, understanding the risks conferred by each access site for valve delivery-notably stroke, vascular injury, and major bleeding-is of paramount importance when selecting the approach that will best optimize the outcome for an individual. In this review, we provide a comprehensive summary of alternative approaches to transfemoral arterial TAVR as well as the available outcome data supporting each of these various techniques.
随着经导管主动脉瓣置换术(TAVR)的出现,与传统手术相比,适当选择的中、高和极高风险的严重主动脉瓣狭窄(AS)患者现在有了一种侵入性较小的选择。在当代实践中,TAVR主要通过经股动脉途径进行,即通过经导管心脏瓣膜(THV)以逆行方式通过髂股动脉系统和胸腹主动脉输送到天然主动脉瓣环。虽然大多数患者具有适合经股动脉入路的解剖结构,但有一部分患有广泛外周血管疾病的患者无法采用这种传统的TAVR方法。幸运的是,结构性心脏病领域的创新促使了用于输送THV的替代入路选项得到完善。选择最合适的治疗途径需要仔细考虑多个因素,包括患者解剖结构、技术可行性和设备规格。此外,在选择最能优化个体治疗效果的方法时,了解每个瓣膜输送入路部位所带来的风险——尤其是中风、血管损伤和大出血——至关重要。在本综述中,我们全面总结了经股动脉TAVR的替代方法以及支持这些不同技术的现有疗效数据。